196 related articles for article (PubMed ID: 33443666)
1. Movement disorders in primary central nervous system lymphoma: two unreported cases and a review of literature.
Grillo P; DI Giuliano F; Massa R; Mercuri NB; Schirinzi T
Neurol Sci; 2021 Mar; 42(3):905-910. PubMed ID: 33443666
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
3. Primary central nervous system lymphoma presenting with a parkinsonian syndrome of pure akinesia.
Pramstaller PP; Salerno A; Bhatia KP; Prugger M; Marsden CD
J Neurol; 1999 Oct; 246(10):934-8. PubMed ID: 10552241
[TBL] [Abstract][Full Text] [Related]
4. Primary Central Nervous System Lymphoma (PCNSL) - A Rare and Unusual Presentation of Rapidly Progressive Major Cognitive Dysfunction.
Nand L; Gupta D; Sharma S; Kumar S
J Assoc Physicians India; 2021 Feb; 69(2):68-70. PubMed ID: 33527818
[TBL] [Abstract][Full Text] [Related]
5. Primary central nervous system lymphoma involving the hypothalamic-pituitary axis: a case series and pooled analysis.
Shin DW; Kim JH; Kim YH; Cho YH; Hong SH
J Neurooncol; 2020 Apr; 147(2):339-349. PubMed ID: 32221784
[TBL] [Abstract][Full Text] [Related]
6. Eye involvement in primary central nervous system lymphoma.
Farrall AL; Smith JR
Surv Ophthalmol; 2020; 65(5):548-561. PubMed ID: 32057762
[TBL] [Abstract][Full Text] [Related]
7. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of primary central nervous system lymphoma.
Han CH; Batchelor TT
Cancer; 2017 Nov; 123(22):4314-4324. PubMed ID: 28950405
[TBL] [Abstract][Full Text] [Related]
9. Atypical presentation of primary central nervous system non-Hodgkin lymphoma in immunocompetent young adults.
Cheatle JT; Aizenberg MR; Weinberg JS; Surdell DL
World Neurosurg; 2013; 79(3-4):593.e9-13. PubMed ID: 22885166
[TBL] [Abstract][Full Text] [Related]
10. Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series.
Patel MP; Kirkpatrick JP; Johnson MO; Healy P; Herndon JE; Lipp ES; Miller ES; Desjardins A; Randazzo D; Friedman HS; Ashley DM; Peters KB
J Neurooncol; 2020 Apr; 147(2):477-483. PubMed ID: 32140975
[TBL] [Abstract][Full Text] [Related]
11. Primary central nervous system lymphoma.
Gerstner ER; Batchelor TT
Arch Neurol; 2010 Mar; 67(3):291-7. PubMed ID: 20212226
[TBL] [Abstract][Full Text] [Related]
12. From the ER to the OR: Initial Evaluation of Primary Central Nervous System Lymphoma.
Baskaran AB; Dixit KS; Sonabend AW; Horbinski CM; Abutalib SA; Lukas RV
Neurologist; 2023 May; 28(3):135-142. PubMed ID: 37027168
[TBL] [Abstract][Full Text] [Related]
13. Analysis of immunoglobulin H gene rearrangement by polymerase chain reaction in primary central nervous system lymphoma.
Kros JM; Bagdi EK; Zheng P; Hop WC; Driesse MJ; Krenacs L; Dinjens WN
J Neurosurg; 2002 Dec; 97(6):1390-6. PubMed ID: 12507138
[TBL] [Abstract][Full Text] [Related]
14. Primary central nervous system lymphoma: essential points in diagnosis and management.
Paydas S
Med Oncol; 2017 Apr; 34(4):61. PubMed ID: 28315229
[TBL] [Abstract][Full Text] [Related]
15. Machine learning applications for the differentiation of primary central nervous system lymphoma from glioblastoma on imaging: a systematic review and meta-analysis.
Nguyen AV; Blears EE; Ross E; Lall RR; Ortega-Barnett J
Neurosurg Focus; 2018 Nov; 45(5):E5. PubMed ID: 30453459
[TBL] [Abstract][Full Text] [Related]
16. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
[TBL] [Abstract][Full Text] [Related]
17. Cognitive functioning and health-related quality of life in patients with newly diagnosed primary CNS lymphoma: a systematic review.
van der Meulen M; Dirven L; Habets EJJ; van den Bent MJ; Taphoorn MJB; Bromberg JEC
Lancet Oncol; 2018 Aug; 19(8):e407-e418. PubMed ID: 30102235
[TBL] [Abstract][Full Text] [Related]
18. Primary CNS Lymphoma.
Grommes C; DeAngelis LM
J Clin Oncol; 2017 Jul; 35(21):2410-2418. PubMed ID: 28640701
[TBL] [Abstract][Full Text] [Related]
19. Challenges and opportunities in primary CNS lymphoma: A systematic review.
Kerbauy MN; Moraes FY; Lok BH; Ma J; Kerbauy LN; Spratt DE; Santos FP; Perini GF; Berlin A; Chung C; Hamerschlak N; Yahalom J
Radiother Oncol; 2017 Mar; 122(3):352-361. PubMed ID: 28104300
[TBL] [Abstract][Full Text] [Related]
20. Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma.
Bödör C; Alpár D; Marosvári D; Galik B; Rajnai H; Bátai B; Nagy Á; Kajtár B; Burján A; Deák B; Schneider T; Alizadeh H; Matolcsy A; Brandner S; Storhoff J; Chen N; Liu M; Ghali N; Csala I; Bagó AG; Gyenesei A; Reiniger L
J Neuropathol Exp Neurol; 2020 Feb; 79(2):176-183. PubMed ID: 31886867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]